Re: A Comparative Study of Robot-assisted and Open Radical Prostatectomy in 10 790 Men Treated by Highly Trained Surgeon...
Published in European urology
Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Gr...
...Published in European urology
Grade groups (GGs) are an important parameter for therapeutic decision making in prostate cancer (Pca) patients. Invasive cribriform and/or intraductal carcinoma (CR/IDC) has an independent prognostic value for disease outcome, but are not included in the GG limiting their clinical use. To perform a proof-of-principle study incorporating CR/IDC in ...
Is There Enough Support for a New Prostate Grading System Factoring in Intraductal Carcinoma and Cribriform Cancer?
Published in European urology
Cardiovascular Disease and the Androgen Receptor: Here We Go Again?
Published in European urology
Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer ...
...Published in European urology
Elderly patients (≥65yr) with advanced prostate cancer and cardiovascular disease (CVD) conditions are often excluded from clinical trials of abiraterone acetate (AA) or enzalutamide (ENZ). Consequently, little is known about the effects of these medications on these vulnerable patients. To assess the short-term outcomes of AA and ENZ in patients w...
Re: Identification and Characterization of Circulating Tumor Cells in Men Who Have Undergone Prostatectomy of Clinically...
Published in European urology
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multi...
...Published in European urology
Androgen deprivation therapy improves the survival of castration-resistant prostate cancer (CRPC) patients, yet ultimately fails with debilitating side effects. Supraphysiological testosterone (SPT)-based therapy produces clinical responses with improved quality of life in a subset of patients. Currently, no information defines a durable response t...
Supraphysiologic Testosterone Solutions for Enzalutamide-resistant Prostate Cancer.
Published in European urology
What Goes Up Must Come Down: Identifying Truth from Global Prostate Cancer Epidemiology.
Published in European urology
Re: PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients w...
Published in European urology
